Legal Representation
Attorney
Alicia M. Passerin
USPTO Deadlines
Next Deadline
909 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180710)
Due Date
July 10, 2028
Grace Period Ends
January 10, 2029
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 16, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Aug 16, 2025 | C15P | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| May 15, 2025 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Nov 20, 2024 | PR23 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | Loading... |
| Nov 20, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 6, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jul 10, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jun 9, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 10, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 24, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 24, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 4, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 20, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 13, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 9, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 2, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes
First Use Anywhere:
19940000
First Use in Commerce:
19940000
Class 005
[ Cells for clinical, medical, veterinary, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, veterinary, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, veterinary, and therapeutic purposes; Kits comprised of cells, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, veterinary, and therapeutic purposes ]
First Use Anywhere:
19940000
First Use in Commerce:
19940000
Class 042
Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto
First Use Anywhere:
20050000
First Use in Commerce:
20050000
Additional Information
Pseudo Mark
NANT KWEST NINETY TWO
Classification
International Classes
001
005
042